Pediatric Extrapolation in Type 2 Diabetes: Future Implications of a Workshop.
Journal
Clinical pharmacology and therapeutics
ISSN: 1532-6535
Titre abrégé: Clin Pharmacol Ther
Pays: United States
ID NLM: 0372741
Informations de publication
Date de publication:
07 2020
07 2020
Historique:
received:
06
11
2019
accepted:
27
01
2020
pubmed:
6
2
2020
medline:
17
2
2021
entrez:
5
2
2020
Statut:
ppublish
Résumé
Extrapolation from adults to youth with type 2 diabetes (T2D) is challenged by differences in disease progression and manifestation. This manuscript presents the results of a mock-team workshop focused on examining the typical team-based decision process used to propose a pediatric development plan for T2D addressing the viability of extrapolation. The workshop was held at the American Society for Clinical Pharmacology and Therapeutics (ASCPT) in Orlando, Florida on March 21, 2018.
Identifiants
pubmed: 32017043
doi: 10.1002/cpt.1805
pmc: PMC7383960
doi:
Substances chimiques
Hypoglycemic Agents
0
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
29-39Informations de copyright
© 2020 The Authors. Clinical Pharmacology & Therapeutics published by Wiley Periodicals, Inc. on behalf of American Society for Clinical Pharmacology and Therapeutics.
Références
CPT Pharmacometrics Syst Pharmacol. 2016 Mar;5(3):93-122
pubmed: 27069774
Diabetes Care. 2005 Apr;28(4):902-9
pubmed: 15793193
N Engl J Med. 2006 Dec 7;355(23):2427-43
pubmed: 17145742
Diabetes. 2019 Aug;68(8):1670-1680
pubmed: 31178433
Pharm Stat. 2014 Jan-Feb;13(1):41-54
pubmed: 23913901
Diabetes Care. 2014 Oct;37(10):2665-7
pubmed: 25249667
Diabetes Care. 2016 Jan;39(1):110-7
pubmed: 26577415
JAMA Pediatr. 2013 Oct;167(10):926-32
pubmed: 23921678
J Clin Pharmacol. 2017 Apr;57(4):469-475
pubmed: 27649629
J Clin Endocrinol Metab. 2002 Oct;87(10):4817-20
pubmed: 12364479
Clin Pediatr Endocrinol. 2018;27(1):1-8
pubmed: 29403151
CPT Pharmacometrics Syst Pharmacol. 2019 May;8(5):259-272
pubmed: 30667172
Diabetes Ther. 2016 Sep;7(3):455-71
pubmed: 27312794
Diabetes Care. 2015 Dec;38(12):2285-92
pubmed: 26537182
Clin Pharmacokinet. 2017 Jun;56(6):561-571
pubmed: 27832452
J Pharm Sci. 2012 May;101(5):1659-71
pubmed: 22383396
Diabetes Obes Metab. 2016 Jul;18(7):678-84
pubmed: 27291448
Interface Focus. 2016 Apr 6;6(2):20150075
pubmed: 27051506
J Clin Endocrinol Metab. 2011 Jan;96(1):159-67
pubmed: 20962021
Clin Pharmacol Ther. 2018 Mar;103(3):419-433
pubmed: 29277892
Diabetes Care. 2014 Dec;37(12):3336-44
pubmed: 25414389
Int J Pediatr. 2013;2013:972034
pubmed: 24260037
Diabetes Care. 2018 Aug;41(8):1696-1706
pubmed: 29941497
Diabetes Care. 2018 Aug;41(8):1707-1716
pubmed: 29941498
N Engl J Med. 2012 Jun 14;366(24):2247-56
pubmed: 22540912
Pediatr Diabetes. 2018 Jun;19(4):649-655
pubmed: 29271103
Diabetes Care. 2009 Jan;32(1):100-5
pubmed: 18835946
J Clin Invest. 1999 Sep;104(6):787-94
pubmed: 10491414
Diabet Med. 2018 Aug;35(8):1096-1104
pubmed: 29655290
Diabetes Care. 2016 Sep;39(9):1635-42
pubmed: 27486237
Pharm Stat. 2017 Jul;16(4):232-249
pubmed: 28448684
J Biol Chem. 2014 Nov 28;289(48):33215-30
pubmed: 25320095
Ther Innov Regul Sci. 2017 May 1;51(3):360-371
pubmed: 28674673